Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report

Afatinib has improved the prognosis of epidermal growth factor receptor-positive advanced non-small cell lung cancer and has been explored in the treatment of human epidermal growth factor receptor 2 (HER2)-amplified breast cancer. However, its clinical efficacy in HER2-amplified endometrial cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615020/
https://www.ncbi.nlm.nih.gov/pubmed/31308701
http://dx.doi.org/10.2147/OTT.S206732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615020/
https://www.ncbi.nlm.nih.gov/pubmed/31308701
http://dx.doi.org/10.2147/OTT.S206732

Ejemplares similares